Cancer Chemotherapy Flashcards
which stage of cancer has quick doubling times, high growth fraction
early stage cancer
late phase cancer has
long doubling times, low growth fraction
describe the cell cycle
- Mitosis
- G0 resting stage comes off mitosis before G1
- G1
- enzyme production
- growth and metabolism
- S phase (synthesis)
- DNA replication
- G2
- growth and preparation fo cell division
- RNA synthesis spindle forms
the growth fraction is
the percent of cells not in G0
what do cell cycle specific anti-cancer agents need to take into consideration
- doubling time and target therapy course and scheduling
- growth fraction
- type of cancner and stage
- resistance
what are 3 objectives of cancer chemotherapy
- curative
- induce complete remission
- palliative
- allieviate symptoms
- adjunct
- improve chances for cure or prevent growth of new cancerous tissue
- e.g. chemo after breast resection
what are the goals of therapy (5 things)
- removal or destruction of cancerous cells while minimizing toxic effects
- minimize resistance by use of more than one drug at a time maximizing kill
- developign a dosage regimen that is often based as much upon pt tolerability as tumor response to therapy
- administer locally to produce high concentration in limited area
- used in combination with surgery or radiotherapy
what are some characteristics of cancer cells
- divide rapidly, uncontrolled growth
a carcinoma is
- solid tissue
- epithelial cells
sarcoma
cancer of connective or mesenchymal tissue
leukemia/lymphoma is
- cancer of hematopoetic system
when you have rapidly dividing cells you should use
antineoplastic agents
slow growing cells
cell cycle specific agents
what are issues with cancer drugs
- very toxic
- kill both cancerous and rapidly dividing non-cancerous cells
- better at killing cells that are progressing through cell cycle than at resting phase
*
what are rapidly dividing cells in the body often impacted by chemo
- hair follicles
- bone marrow
- intestinal epitheilium
what are some things to consider in drug selection (5)
- use drugs that show activity or efficacy against the type of cancer being treated
- should not be x-resistant
- there should be minimal or no overlapping toxicity between drugs
- decrease AEs
- side effects not centered around same organ
- dosing shechule should be optimal and at consistent times
- use doubling time to plan dosing
- allow time for recovery of sensitive cells (bone marrow) b/t treatments
- should use drug compbinations with synergistic effects
- optimizing therapeutic benefit
- decrease risk and severity of AEs
- use drugs with different mechanism of action or that effect tumor at different stages of cell cycle
- more kill each cycle
cytotoxic drugs include these classes (8)
- alkylating agents
- microtubule inhibitors
- enzyme inhibitors
- antimetabolites
- protein kinase inhibitors
- monoclonal antibodies
- hormonal therapy
- immunomodulators
damage or disrupt DNA synthesis
alkylating agents